Sort   by:  
 Page size 
UnknownEarly Serial Echocardiographic and Ultrasonographic Findings in Critically Ill Patients With COVID-19.
Not available
S-EPMC10030437 | biostudies-literature
UnknownProgression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age.
Not available
S-EPMC3725578 | biostudies-literature
UnknownSCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.
Not available
S-EPMC2780008 | biostudies-literature
UnknownMetformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC12261116 | biostudies-literature
UnknownTime to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC11581631 | biostudies-literature
UnknownHigher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC10656670 | biostudies-literature
UnknownA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Not available
S-EPMC2806600 | biostudies-literature
UnknownA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.
Not available
S-EPMC2872173 | biostudies-literature
UnknownIncidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Not available
S-EPMC6639714 | biostudies-literature
UnknownCost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.
Not available
S-EPMC9896372 | biostudies-literature
Sort   by:  
 Page size